Citation Impact
Citing Papers
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001
2003
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Survival of children with bone sarcoma in Europe since 1978
2001
The WHO Classification of Tumors of the Nervous System
2002 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia.
1993
Improved outcome in central nervous system aspergillosis, using voriconazole treatment
2005
A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family
2002
Aspergillus Tracheobronchitis
2012
Ondansetron
1991
Consensus Guidelines for Managing Postoperative Nausea and Vomiting
2003 Standout
Endobronchial Fungal Disease: An Under-Recognized Entity
2006
COVID-19: A promising cure for the global panic
2020 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans
2004
Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity
1996
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
2001
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Osteosarcoma
2010 Standout
Ondansetron versus Chlorpromazine for Preventing Emesis in Bone Marrow Transplant Recipients: a Double-Blind Randomized Study
1993
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting
2007
Ondansetron
2001
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Review of the safety and efficacy of voriconazole
2002
Aspergillosis
2002
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Cerebral aspergillosis: tissue penetration is the key
2009
Graft-versus-host disease
2009 Standout
Echinocandin antifungal drugs
2003 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
2013 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
GRADE guidelines 6. Rating the quality of evidence—imprecision
2011 Standout
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Ondansetron: A Serotonin Receptor (5-HT3) Antagonist for Antineoplastic Chemotherapy-Induced Nausea and Vomiting
1991
Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy The Rizzoli experience in 52 patients
2006
Attitudes towards and participation in randomised clinical trials in oncology: A review of the literature
2000
Voriconazole: A New Triazole Antifungal Agent
2003 Standout
Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors
2010
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
2007
Participation Rates in Epidemiologic Studies
2007 Standout
Therapeutic use ofCannabis sativaon chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis
2008
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
1991 Standout
Immunity to fungal infections
2011 Standout
Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
2011
Auditory complications in childhood cancer survivors: A report from the childhood cancer survivor study
2011
Transfusion-Associated Graft-versus-Host Disease
1990
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus
2013 StandoutNobel
Practice Guidelines for Diseases Caused by Aspergillus
2000
Aspergillus Meningitis: Diagnosis by Non-Culture-Based Microbiological Methods and Management
1999
High-dose dexamethasone for prevention of cis-platin-induced vomiting
1981
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale
2012
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood
2016
Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission
1994
Randomized Comparison of Low-Dose Involved-Field Radiotherapy and No Radiotherapy for Children With Hodgkin’s Disease Who Achieve a Complete Response to Chemotherapy
2002
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
AspergillusInfections in Transplant Recipients
2005
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
2012
A Phase II Study of Delta-9-Tetrahydrocannabinol for Appetite Stimulation in Cancer-Associated Anorexia
1994
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Auditory Late Effects of Childhood Cancer Therapy: A Report From the Children's Oncology Group
2010
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
1999
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Successful Treatment of Cerebral Aspergillosis with a High Oral Dose of Itraconazole after Excisional Surgery.
1999
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
2003
Granulocyte Colony-Stimulating Factor Reduces the Capacity of Blood Mononuclear Cells to Induce Graft-Versus-Host Disease: Impact on Blood Progenitor Cell Transplantation
1997
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies
2015
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Delta‐9‐tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double‐blind, randomized study
1999
Cannabinoids for Medical Use
2015 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.
1983
Successful treatment of pulmonary and cerebral aspergillosis in an immunosuppressed child
1982
Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
2005
Review of Cannabinoids and their Antiemetic Effectiveness
1983
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Cisplatin
1984 Standout
Works of Keith Waters being referenced
Childhood cancer in Victoria, Australia, 1970–1989
1995
Enhanced cis‐platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation
1989
Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia.
1990
Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child
2001
TESTICULAR AND PARATESTICULAR TUMOURS IN CHILDREN: 30 YEARS’ EXPERIENCE
1999
Aspergillus laryngotracheobronchial infection in a 6-year-old girl following bone marrow transplantation
2001
Sensitive and Specific Measurement of Minimal Residual Disease in Acute Lymphoblastic Leukemia
2009
EWS/FLI-1 Fusion Transcript Detection and MIC2 Immunohistochemical Staining in the Diagnosis of Ewing's Sarcoma
1996
Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.
1988
Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia
2009
AMELIORATION OF CANCER CHEMOTHERAPY‐INDUCED NAUSEA AND VOMITING BY DELTA‐9‐TETRAHYDRO‐CANNABINOL
1979
Bilateral metachronous periosteal osteosarcoma
1986
Prophylactic Co‐trimoxazole and lactobacilli preparation in neutropenic patients
1980
Importance of Minimal Residual Disease Testing During the Second Year of Therapy for Children With Acute Lymphoblastic Leukemia
2003
A randomized study of intermittent chemotherapy with or without BCG inoculation in maintenance therapy of childhood ALL
1980
MARROW FUNCTION RECONSTITUTION BY FRACTION 3 OF PERCOLL-DENSITY-GRADIENT-SEPARATED CELLS
1986
EXTRADURAL CHLOROMA WITH SPINAL COMPRESSION—AN UNUSUAL PRESENTATION OF ACUTE MYELOGENOUS LEUKEMIA
1984
POOR OUTLOOK FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA WITH RELAPSE
1979
Primitive neuroectodermal tumour of the central nervous system associated with malignant rhabdoid tumour of the kidney: report of a case
1986
EWS/FLI-1 Fusion Transcript Detection and MIC2 Immunohistochemical Staining in the Diagnosis of Ewing's Sarcoma
1996
Invasive Central Nervous System Aspergillosis
1995